Drawing for ENDOSYME OBI

USPTO serial 98287135

ENDOSYME OBI

Reviewed by CopyMark Law Group

Reg. 7933685Status 700Registered
Filing date
Status date
Registration date
Sep 9, 2025
Examiner
OSBORNE, AUDRIANA R
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ENDOSYME OBI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ran He

10611 HARWIN DR. SUITE 406HOUSTON, TX 77036United States

Goods and services

ClassDescriptionStatusFirst use
005Immunostimulants; Vaccines; Adjuvants for medical purposes; Anti-cancer preparations; Biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer to be prevented or treated; Chemical reagents for medical or veterinary purposes; Enzyme preparations for medical purposes; Enzymes for medical purposes; Ferments for pharmaceutical purposes; Hormones for medical purposes; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Preparations of microorganisms for medical purposes; Tumor suppressing agentsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 9, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 9, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 22, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 22, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 16, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 27, 2025ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Apr 10, 2025ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Feb 24, 2025OTHECASE RETURNED TO EXAMINATION—
Feb 24, 2025IUCNNOTICE OF ALLOWANCE CANCELLED—
Feb 14, 2025JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Feb 14, 2025PCBGPETITION TO DIRECTOR - CHANGE BASIS - GRANTED—
Feb 13, 2025APETASSIGNED TO PETITION STAFF—
Jan 3, 2025TPADTEAS PETITION TO AMEND BASIS RECEIVED—
Oct 1, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 6, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 6, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 17, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 27, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 27, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Jun 27, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 27, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 27, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 26, 2024DOCKASSIGNED TO EXAMINER—
Mar 26, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 26, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 26, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 19, 2024MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jan 18, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 1, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance